An X-ray inactivated vaccine against Pseudomonas aeruginosa Keratitis in mice

Vaccine. 2023 Jul 19;41(32):4700-4709. doi: 10.1016/j.vaccine.2023.05.066. Epub 2023 Jun 21.

Abstract

Pseudomonas aeruginosa (P. aeruginosa) is one of the most prevalent pathogens of bacterial keratitis. Bacterial keratitis is a major cause of blindness worldwide. The rising incidence of multidrug resistance of P. aeruginosa precludes treatment with conventional antibiotics. Herein, we evaluated the protective efficiency and explored the possible underlying mechanism of an X-ray inactivated vaccine (XPa) using a murine P. aeruginosa keratitis model. Mice immunized with XPa exhibit reduced corneal bacterial loads and pathology scores. XPa vaccination induced corneal macrophage polarization toward M2, averting an excessive inflammatory reaction. Furthermore, histological observations indicated that XPa vaccination suppressed corneal fibroblast activation and prevented irreversible visual impairment. The potency of XPa against keratitis highlights its potential utility as an effective and promising vaccine candidate for P. aeruginosa.

Keywords: Macrophage polarization; P. aeruginosa keratitis; P. aeruginosa vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cornea / microbiology
  • Cornea / pathology
  • Eye Infections, Bacterial* / microbiology
  • Eye Infections, Bacterial* / pathology
  • Eye Infections, Bacterial* / prevention & control
  • Keratitis* / drug therapy
  • Keratitis* / microbiology
  • Keratitis* / prevention & control
  • Mice
  • Mice, Inbred C57BL
  • Pseudomonas Infections* / prevention & control
  • Pseudomonas aeruginosa
  • Vaccines, Inactivated / therapeutic use
  • X-Rays

Substances

  • Vaccines, Inactivated